Literature DB >> 15290853

Physicochemical evaluation, in vitro human skin diffusion, and concurrent biotransformation of 3-O-alkyl carbonate prodrugs of naltrexone.

Omathanu Pillai1, Mohamed O Hamad, Peter A Crooks, Audra L Stinchcomb.   

Abstract

PURPOSE: The purpose of this study was to evaluate the physicochemical properties and in vitro human skin diffusion of the 3-O-alkyl carbonate prodrugs of naltrexone (NTX).
METHODS: Melting points and heats of fusion (deltaHf) were determined using differential scanning calorimetry. In vitro human skin permeation rates of NTX and its prodrugs were measured using a flowthrough diffusion cell system. Drug disposition in the skin was quantified at the end of the diffusion experiment. The solubilities of the drugs were determined in mineral oil and isotonic buffer. Partitioning of the prodrugs from vehicle to skin was determined using isolated sheets of human stratum corneum (SC).
RESULTS: All the prodrugs hydrolyzed to NTX on passing through the skin, and the methyl NTX-3-O-carbonate (ME-NTX) provided the highest NTX flux, apparent permeability coefficient (Kp), and calculated relative thermodynamic activity from the melting point and deltaHf. The ME-NTX SC/vehicle partition coefficient was the highest of the prodrug series, although similar to the NTX SC/vehicle partition coefficient value. The shortest chain prodrugs underwent the highest extent of bioconversion to NTX upon passing through the skin.
CONCLUSIONS: Within this 3-O-alkyl carbonate prodrug series, the shortest chain prodrug was the most skin-permeable compound with the highest partition coefficient and a significant extent of bioconversion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15290853     DOI: 10.1023/b:pham.0000033000.03652.73

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  PREPARATION OF ISOLATED SHEETS OF HUMAN STRATUM CORNEUM.

Authors:  A M KLIGMAN; E CHRISTOPHERS
Journal:  Arch Dermatol       Date:  1963-12

2.  A solubility and related physicochemical property comparison of buprenorphine and its 3-alkyl esters.

Authors:  A L Stinchcomb; R Dua; A Paliwal; R W Woodard; G L Flynn
Journal:  Pharm Res       Date:  1995-10       Impact factor: 4.200

3.  Optimization of topical therapy: partitioning of drugs into stratum corneum.

Authors:  C Surber; K P Wilhelm; M Hori; H I Maibach; R H Guy
Journal:  Pharm Res       Date:  1990-12       Impact factor: 4.200

4.  Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin.

Authors:  Audra L Stinchcomb; Peter W Swaan; Opinya Ekabo; Kathleen K Harris; Jennifer Browe; Dana C Hammell; Todd A Cooperman; Michael Pearsall
Journal:  J Pharm Sci       Date:  2002-12       Impact factor: 3.534

5.  Modeling of diffusion and concurrent metabolism in cutaneous tissue.

Authors:  P Boderke; K Schittkowski; M Wolf; H P Merkle
Journal:  J Theor Biol       Date:  2000-06-07       Impact factor: 2.691

6.  Naltrexone and alcohol dependence. Role of subject compliance.

Authors:  J R Volpicelli; K C Rhines; J S Rhines; L A Volpicelli; A I Alterman; C P O'Brien
Journal:  Arch Gen Psychiatry       Date:  1997-08

7.  Prediction of transdermal flux of prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine with a series/parallel model.

Authors:  W J Roberts; K B Sloan
Journal:  J Pharm Sci       Date:  2000-11       Impact factor: 3.534

8.  Improvement of the oral bioavailability of naltrexone in dogs: a prodrug approach.

Authors:  M A Hussain; C A Koval; M J Myers; E G Shami; E Shefter
Journal:  J Pharm Sci       Date:  1987-05       Impact factor: 3.534

9.  Behavioral naltrexone therapy: an integrated treatment for opiate dependence.

Authors:  Jami L Rothenberg; Maria A Sullivan; Sarah H Church; Angela Seracini; Eric Collins; Herbert D Kleber; Edward V Nunes
Journal:  J Subst Abuse Treat       Date:  2002-12

10.  Naltrexone in the treatment of alcohol dependence.

Authors:  J R Volpicelli; A I Alterman; M Hayashida; C P O'Brien
Journal:  Arch Gen Psychiatry       Date:  1992-11
View more
  11 in total

1.  Novel 3-O-pegylated carboxylate and 3-O-pegylated carbamate prodrugs of naltrexone for microneedle-enhanced transdermal delivery.

Authors:  Thirupathi Reddy Yerramreddy; Mikolaj Milewski; Narsimha Reddy Penthala; Audra L Stinchcomb; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2010-04-18       Impact factor: 2.823

Review 2.  Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; Robert Landsiedel
Journal:  Arch Toxicol       Date:  2018-06-18       Impact factor: 5.153

3.  Microneedle-assisted percutaneous delivery of naltrexone hydrochloride in yucatan minipig: in vitro-in vivo correlation.

Authors:  Mikolaj Milewski; Kalpana S Paudel; Nicole K Brogden; Priyanka Ghosh; Stan L Banks; Dana C Hammell; Audra L Stinchcomb
Journal:  Mol Pharm       Date:  2013-09-23       Impact factor: 4.939

4.  Human skin permeation of branched-chain 3-0-alkyl ester and carbonate prodrugs of naltrexone.

Authors:  Haranath K Vaddi; Mohamed O Hamad; Jianhong Chen; Stan L Banks; Peter A Crooks; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

5.  Synthesis and in vitro stability of amino acid prodrugs of 6-β-naltrexol for microneedle-enhanced transdermal delivery.

Authors:  Joshua A Eldridge; Mikolaj Milewski; Audra L Stinchcomb; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2014-10-02       Impact factor: 2.823

Review 6.  Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; K Guth; R Landsiedel
Journal:  Arch Toxicol       Date:  2014-11-05       Impact factor: 5.153

7.  In vitro/in vivo correlation of transdermal naltrexone prodrugs in hairless guinea pigs.

Authors:  Satyanarayana Valiveti; Kalpana S Paudel; Dana C Hammell; Mohamed O Hamad; Jianhong Chen; Peter A Crooks; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

8.  Transdermal delivery of bupropion and its active metabolite, hydroxybupropion: a prodrug strategy as an alternative approach.

Authors:  Paul K Kiptoo; Kalpana S Paudel; Dana C Hammell; Raghotham Reddy Pinninti; Jianhong Chen; Peter A Crooks; Audra L Stinchcomb
Journal:  J Pharm Sci       Date:  2009-02       Impact factor: 3.534

9.  Human skin permeation of 3-O-alkyl carbamate prodrugs of naltrexone.

Authors:  Haranath K Vaddi; Stan L Banks; Jianhong Chen; Dana C Hammell; Peter A Crooks; Audra L Stinchcomb
Journal:  J Pharm Sci       Date:  2009-08       Impact factor: 3.534

10.  Preparation of mixed trialkyl alkylcarbonate derivatives of etidronic acid via an unusual route.

Authors:  Petri A Turhanen; Janne Weisell; Jouko J Vepsäläinen
Journal:  Beilstein J Org Chem       Date:  2012-11-20       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.